Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

By sjmartinez • May 31, 2024

Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 May 30. doi: 10.1007/s13555-024-01188-y. Epub ahead of print. PMID: 38814433.

Tags: ACR response, Biologic DMARDs, Body surface area, Dermatology, Disease activity, ixekizumab, psoriasis, psoriatic arthritis, Publications

Low-Dose Oral Minoxidil Use for Pediatric Hair Disorders: An International Consensus Statement

Akiska YM, Fu J, Castelo-Soccio L, Mathes E, Mirmirani P, Jamerson T, Sibbald C; and The Pediatric Low-Dose Oral Minoxidil Consensus Expert Group; Spagnol Abraham[...]

Robustness of Network Meta-Analysis in Chronic Plaque Psoriasis-Reply

Armstrong AW, Nong Y, Merola JF. Robustness of Network Meta-Analysis in Chronic Plaque Psoriasis-Reply. JAMA Dermatol. 2026 Sep 23. doi: 10.1001/jamadermatol.2026.3645. Epub ahead of print.[...]

Moderate-to-severe chronic spontaneous urticaria is associated with increased risk of immune-mediated diseases: A population-based study

Smart K, Ure A, Johnsen N, Aflatooni S, Cortes JA, Palma G, Nong Y, Borba AJ, Levins PC, Armstrong AW. Moderate-to-severe chronic spontaneous urticaria is[...]